Myasthenia gravis with antibodies to MuSK: an update.

about

Myasthenia gravis with antibodies to MuSK: an update.

Item

http://www.wikidata.org/entity/Q47674286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Myasthenia gravis with antibodies to MuSK: an update.

@en

Myasthenia gravis with antibodies to MuSK: an update.

@nl

type

Item

label

Myasthenia gravis with antibodies to MuSK: an update.

@en

Myasthenia gravis with antibodies to MuSK: an update.

@nl

prefLabel

Myasthenia gravis with antibodies to MuSK: an update.

@en

Myasthenia gravis with antibodies to MuSK: an update.

@nl

P1476

Myasthenia gravis with antibodies to MuSK: an update.

@en

P2093

Amelia Evoli

http://www.w3.org/2001/XMLSchema#string

Carlo Provenzano

http://www.w3.org/2001/XMLSchema#string

Emanuela Bartoccioni

http://www.w3.org/2001/XMLSchema#string

Mariapaola Marino

http://www.w3.org/2001/XMLSchema#string

Paolo E Alboini

http://www.w3.org/2001/XMLSchema#string

Raffaele Iorio

http://www.w3.org/2001/XMLSchema#string

Valentina Damato

http://www.w3.org/2001/XMLSchema#string

P2860

International consensus guidance for management of myasthenia gravis: Executive summary

International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease

Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody

Lrp4 is a retrograde signal for presynaptic differentiation at neuromuscular synapses

Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis

PML in a patient with myasthenia gravis treated with multiple immunosuppressing agents.

Poly-autoimmunity in patients with myasthenia gravis: A single-center experience.

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.

Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

P304

82-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1111/NYAS.13518

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

1412

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29266255

http://www.w3.org/2001/XMLSchema#string

P921

myasthenia gravis